UCB SA (OTC:UCBJY) (OTC:UCBJF) (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ:BIIB) on Thursday presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab ...

UCB is once again partnering with Sandra Lee — also known as Dr. Pimple Popper — for a campaign focused on elevating the awareness of hidradenitis suppurativa (HS). The drugmaker and healthcare ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

Generalized myasthenia gravis (gMG) is a disease that is often debilitating and can limit the lives of patients in countless ways. A severe form of myasthenia gravis (MG), gMG is marked by muscle ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

The next leg of a huge share-price rally for Belgium’s UCB SA — driven by the success of its Bimzelx skin disease medicine — hinges on key results for a rival drug. The Belgian biotech’s stock could ...

PARIS/SINGAPORE, Aug 26 (Reuters) - UCB (UCB.BR), opens new tab, a Belgian biopharmaceutical firm, said on Monday it would sell its Chinese neurology and allergy business to Singapore-based asset ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...